Read More 1 minute read Analyst Ratings News Price Target Wells Fargo Maintains Overweight on Highwoods Props, Lowers Price Target to $40 By Benzinga Newsdesk July 1, 8:43 AM Wells Fargo analyst Blaine Heck maintains Highwoods Props (NYSE:HIW) with a Overweight and lowers the price target from $55 to $40. HIW
Read More 1 minute read Analyst Ratings News Price Target Truist Securities Maintains Buy on Shake Shack, Lowers Price Target to $67 By Benzinga Newsdesk July 1, 8:41 AM Truist Securities analyst Jake Bartlett maintains Shake Shack (NYSE:SHAK) with a Buy and lowers the price target from $86 to $67. SHAK
Read More 1 minute read Analyst Ratings News Price Target Wells Fargo Maintains Overweight on Douglas Emmett, Lowers Price Target to $28 By Benzinga Newsdesk July 1, 8:38 AM Wells Fargo analyst Blaine Heck maintains Douglas Emmett (NYSE:DEI) with a Overweight and lowers the price target from $38 to $28. DEI
Read More 1 minute read Analyst Ratings News Price Target Wells Fargo Maintains Overweight on Cousins Props, Lowers Price Target to $33 By Benzinga Newsdesk July 1, 8:37 AM Wells Fargo analyst Blaine Heck maintains Cousins Props (NYSE:CUZ) with a Overweight and lowers the price target from $45 to $33. CUZ
Read More 1 minute read Analyst Ratings Downgrades News Price Target JP Morgan Downgrades HBT Finl to Underweight, Lowers Price Target to $19 By Benzinga Newsdesk July 1, 8:33 AM JP Morgan analyst Steven Alexopoulos downgrades HBT Finl (NASDAQ:HBT) from Neutral to Underweight and lowers the price target from $20 to $19. HBT
Read More 2 minute read General Medigus Announces Eventer Signs Agreements With Two Teams From The Israeli Basketball Premier League And The Israeli National Basketball League By Bill Haddad July 1, 8:31 AM Eventer will leverage its capabilities in the sports sector and intends to expand its outreach to leagues in the US and Europe Tel Aviv, Israel, July 01, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) MDGS
Read More 1 minute read Analyst Ratings Initiation News Price Target Benchmark Initiates Coverage On Belite Bio with Buy Rating, Announces Price Target of $57 By Benzinga Newsdesk July 1, 8:29 AM Benchmark analyst Bruce Jackson initiates coverage on Belite Bio (NASDAQ:BLTE) with a Buy rating and announces Price Target of $57. BLTE
Read More 1 minute read Analyst Ratings News Price Target Credit Suisse Maintains Outperform on Acuity Brands, Lowers Price Target to $200 By Benzinga Newsdesk July 1, 8:27 AM Credit Suisse analyst John Walsh maintains Acuity Brands (NYSE:AYI) with a Outperform and lowers the price target from $211 to $200. AYI
Read More 1 minute read Analyst Ratings News Price Target Truist Securities Maintains Buy on Wingstop, Lowers Price Target to $130 By Benzinga Newsdesk July 1, 8:25 AM Truist Securities analyst Jake Bartlett maintains Wingstop (NASDAQ:WING) with a Buy and lowers the price target from $160 to $130. WING
Read More 1 minute read Analyst Ratings News Price Target Wells Fargo Maintains Overweight on Corporate Office Props Tr, Lowers Price Target to $30 By Benzinga Newsdesk July 1, 8:23 AM Wells Fargo analyst Blaine Heck maintains Corporate Office Props Tr (NYSE:OFC) with a Overweight and lowers the price target from $33 to $30. OFC